Conflict of Interest Policies for Organizations Producing a Large Number of Clinical Practice Guidelines
TLDR
COI policies among organizations producing a large number of CPGs currently do not measure up to IOM standards related to COI disclosure and management, and CPG developers need to make significant improvements in these policies and their implementation.Abstract:
Background
Conflict of interest (COI) of clinical practice guideline (CPG) sponsors and authors is an important potential source of bias in CPG development. The objectives of this study were to describe the COI policies for organizations currently producing a significant number of CPGs, and to determine if these policies meet 2011 Institute of Medicine (IOM) standards.
Methodology/Principal Findings
We identified organizations with five or more guidelines listed in the National Guideline Clearinghouse between January 1, 2009 and November 5, 2010. We obtained the COI policy for each organization from publicly accessible sources, most often the organization's website, and compared those polices to IOM standards related to COI. 37 organizations fulfilled our inclusion criteria, of which 17 (46%) had a COI policy directly related to CPGs. These COI policies varied widely with respect to types of COI addressed, from whom disclosures were collected, monetary thresholds for disclosure, approaches to management, and updating requirements. Not one organization's policy adhered to all seven of the IOM standards that were examined, and nine organizations did not meet a single one of the standards.
Conclusions/Significance
COI policies among organizations producing a large number of CPGs currently do not measure up to IOM standards related to COI disclosure and management. CPG developers need to make significant improvements in these policies and their implementation in order to optimize the quality and credibility of their guidelines.read more
Citations
More filters
Book
Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis
TL;DR: A committee of experts to examine the quality of cancer care in the United States and formulate recommendations for improvement presents the committee’s findings and recommendations.
Journal Article
Conflict of Interest in Medical Research, Education, and Practice
TL;DR: The Institute of Medicine’s Conflict of Interest in Medical Research, Education, and Practice makes an important contribution to the continuing debate about financial conflicts of interest in medicine and makes 16 recommendations for reforming medicine, some of which would require radical changes.
Journal ArticleDOI
Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines.
Holger J. Schünemann,Holger J. Schünemann,Lubna A. Al-Ansary,Lubna A. Al-Ansary,Frode Forland,Frode Forland,Sonja Kersten,Sonja Kersten,Jorma Komulainen,Jorma Komulainen,Ina Kopp,Ina Kopp,Fergus Macbeth,Fergus Macbeth,Susan M. Phillips,Susan M. Phillips,Craig Robbins,Craig Robbins,Philip van der Wees,Philip van der Wees,Amir Qaseem,Amir Qaseem +21 more
TL;DR: The Guidelines International Network Board of Trustees as discussed by the authors developed guidance on the disclosure of interests and management of conflicts of interest (COIs) in guideline development, with an increasing recognition of the importance of disclosing and managing indirect COIs.
Journal ArticleDOI
Levers for addressing medical underuse and overuse: achieving high-value health care
Adam G Elshaug,Meredith B. Rosenthal,John N. Lavis,John N. Lavis,Shannon Brownlee,Harald Schmidt,Somil Nagpal,Peter Littlejohns,Divya Srivastava,Sean R. Tunis,Vikas Saini +10 more
TL;DR: A range of levers for eliminating medical underuse and overuse are investigated, some of which could operate effectively (and be politically viable) across many different health and political systems whereas other levers must be tailored to local contexts.
References
More filters
Journal ArticleDOI
Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines.
TL;DR: The potential benefits, limitations, and harms of clinical guidelines are examined, a tool for making care more consistent and efficient and for closing the gap between what clinicians do and what scientific evidence supports.
Journal ArticleDOI
Scottish Intercollegiate Guidelines Network
Sara Twaddle,Safia Qureshi +1 more
TL;DR: This guideline has been assessed for its likely impact on the six equality groups defined by age, disability, gender, race, religion/belief, and sexual orientation.
Journal ArticleDOI
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
TL;DR: Investigating whether funding of drug studies by the pharmaceutical industry is associated with outcomes that are favourable to the funder and whether the methods of trials funded by pharmaceutical companies differ from the methods in trials with other sources of support found systematic bias favours products which are made by the company funding the research.
Book
Clinical Practice Guidelines We Can Trust
TL;DR: Clinical Practice Guidelines The authors Can Trust shows how clinical practice guidelines can enhance clinician and patient decision-making by translating complex scientific research findings into recommendations for clinical practice that are relevant to the individual patient encounter, instead of implementing a one size fits all approach to patient care.
Journal ArticleDOI
Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review
TL;DR: In this article, the authors reviewed original, quantitative studies on the extent, impact, and management of financial conflicts of interest in biomedical research and concluded that financial relationships among industry, scientific investigators, and academic institutions are widespread.